Xeno Transplants Corp
Xeno Transplants Corp. operates as a bio-technology research and development company. It intends to develop therapeutic applications of organs and cells derived from genetically engineered pigs as a transplant alternative to limited human donor sources.
What If You Bought XENO Earlier?
Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.
Stock Split History
Newest split first. Cumulative multiple = compounded growth within the displayed company lineage.
| Split Date | Price Before | Ratio | Split Multiple | Cumulative |
|---|---|---|---|---|
| Sep 6, 2006 | $0.86 | 5-for-2 | 2.5× | 2.5× |
Xeno Transplants Corp Market Cap Timeline
A validated annual market-cap history is unavailable from the current sources. The current market-cap snapshot, when shown above, is not treated as historical evidence. Split markers cover 1 current-security split. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.
At least two source-validated annual observations are required before this page draws a market-cap timeline. A current snapshot is not treated as historical trend data.